WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 4 fonti

Hims & Hers pulls copycat weight-loss pill after threats of legal action

Hims & Hers on Saturday announced it would stop offering its copycat of the weight-loss pill Wegovy after threats of legal action.

Raccontata dacnbc.comfortune.comupi.combbc.com

Confronto fonti

4 prospettive sulla stessa storia
AI · summaries
cnbc.comStai leggendo4 mesi fa

Hims & Hers pulls copycat weight-loss pill after threats of legal action

Hims & Hers on Saturday announced it would stop offering its copycat of the weight-loss pill Wegovy after threats of legal action.

originale
fortune.com4 mesi fa

Hims & Hers scraps copycat Wegovy weight-loss pill after probe | Fortune

The announcement comes a day after the US Food and Drug Administration said it was cracking down on copycat weight-loss treatments.

Leggi questa versione → originale

Timeline cronologica

  1. giovedì 5 febbraio 2026·cnbc.com

    Novo Nordisk and Eli Lilly fall after Hims & Hers announce $49 copy of Wegovy pill

    Novo Nordisk and Eli Lilly fell after Hims & Hers said it will offer a copy of the Wegovy pill for $49, far less than the $149 Novo sells the branded pill for.

  2. venerdì 6 febbraio 2026·cnbc.com

    Hims & Hers falls 8% after Novo's legal threat. Here's the latest

    Hims & Hers stock fall to a 12-month low after Novo said it's $49 Wegovy pill copy was "illegal"

upi.com4 mesi fa

Novo Nordisk suing Hims & Hers over ‘copycat’ weight loss drug - UPI.com

Novo Nordisk, the maker of the weight loss drug Wegovy, is suing Hims & Hers for selling a cheaper version of the drug, the company announced Monday.

Leggi questa versione → originale
bbc.com4 mesi fa

Wegovy maker Novo Nordisk sues rival over 'knock-off' weight-loss drugs

Novo Nordisk says Hims & Hers' drugs breach its patent; Hims & Hers calls the lawsuit a "blatant attack".

Leggi questa versione → originale
  • sabato 7 febbraio 2026·cnbc.com

    US signals crackdown on compounded weight-loss drugs; Hims shares tumble

    The FDA said on Friday it plans to restrict GLP-1 ingredients used in non-approved compounded drugs from companies like Hims & Hers.

  • sabato 7 febbraio 2026·cnbc.com

    Hims & Hers pulls copycat weight-loss pill after threats of legal action

    Hims & Hers on Saturday announced it would stop offering its copycat of the weight-loss pill Wegovy after threats of legal action.

  • sabato 7 febbraio 2026·fortune.com

    Hims & Hers scraps copycat Wegovy weight-loss pill after probe | Fortune

    The announcement comes a day after the US Food and Drug Administration said it was cracking down on copycat weight-loss treatments.

  • lunedì 9 febbraio 2026·cnbc.com

    Novo Nordisk pops 8% after Hims & Hers pulls copycat weight-loss pill

    Novo Nordisk shares jumped 8% Monday after Hims & Hers said it will pull its copycat weight-loss pill off the market.

  • lunedì 9 febbraio 2026·cnbc.com

    Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injections

    Novo is asking the court to permanently ban Hims from selling compounded versions of its drugs that infringe patents, and is seeking to recover damages.

  • lunedì 9 febbraio 2026·upi.com

    Novo Nordisk suing Hims & Hers over ‘copycat’ weight loss drug - UPI.com

    Novo Nordisk, the maker of the weight loss drug Wegovy, is suing Hims & Hers for selling a cheaper version of the drug, the company announced Monday.

  • martedì 10 febbraio 2026·bbc.com

    Wegovy maker Novo Nordisk sues rival over 'knock-off' weight-loss drugs

    Novo Nordisk says Hims & Hers' drugs breach its patent; Hims & Hers calls the lawsuit a "blatant attack".